In 1999, Simon and colleagues identified mutations in the gene PCLN1, subsequently called CLDN16, as the underlying cause of FHHNC [5]. This evidence concerns the gene CLDN16 and familial primary hypomagnesemia with hypercalciuria and nephrocalcinosis.